NGS ANALYSIS PLATFORM

Better Data for Better Health

Geneyx offers a superior NGS data analysis and interpretation platform, harnessing genetic data to guide digital insights for rare and germline disorders. Our AI-based analysis platform streamlines the diagnostics process, from the raw genetic data to the final clinical report. Geneyx develops unique technologies and utilizes diverse databases in the interpretation of WGS (Whole Genome Sequencing), WES, and gene panels. We aim to enrich disease-specific, clinically relevant insights around risk prediction, diagnosis, prognosis, and treatment for clinical and pharmaceutical organizations.
Play Video
Play Video

From analysis to discovery

Accelerating Genetic Diagnosis and Research

Geneyx Analysis

AI-Based Genetic Data Analysis

Geneyx Test

Ready-To-Use Genetic Apps

Geneyx Research

Targeted Drug Discovery

Cases Analyzed

90000

Citations

0

Countries

0

TB of Genetic Data Analyzed

500

GENEYX ANALYSIS

For Hospitals & Labs

 
0 %

Double your diagnostic yield

0 %

Reduce your turn-around time

GENEYX ANALYSIS

For Hospitals & Labs

0 %

Double your diagnostic yield

0 %

Reduce your turn-around time

Knowledgebase

Dozens of Key Data Sources

Integrating dozens of key data sources, the Knowledgebase empowers your Next Generation Sequencing analysis by highlighting associations between genes and phenotypes, providing supporting evidence for immediate evaluation, and automatically generating case reports.

Rapid and accurate phenotype-driven variant prioritization, supporting protein-coding genes and regulatory regions

Leveraging leading integrated regulatory region database.

Enabling rapid evaluation of candidate mutations and automated population of customized reports

Routinely updated with cutting-edge tools and the most recent, relevant data sources

Double the diagnostic yields.
Drastically reduced turnaround time.
Rapid, accurate interpretation.
The implications of this technology? Revolutionary.

Success Stories

See Geneyx In Action

Identifying novel  mutations responsible for colon  cancer predisposition

Prof Revital Kariv, M.D., and her team diagnose and treat patients with colon cancer. In many cases, they identify families with a clear predisposition to develop polyposis and thereafter colon cancer quite early in their lives, implying a strong inherited genetic background for the trait.

Increasing the accuracy and decreasing the time required for  clinical genetic analysis

In 2017, The genetic team at the largest pediatric hospital in Europe, Prof Antonio Novelli and his team of geneticists used to analyze dozens of rare genetic disorder cases per month.
Previous
Next

Our Customers' Experience

In Their Own Words

“Geneyx Analysis is at the highest level, and with extraordinary bioinformatics pipelines”

“The Geneyx platform for genetic analysis is at the highest level, and with extraordinary bioinformatic pipelines. Geneyx will assist us in making impactful discoveries for gene-elusive sudden death arrhythmia syndromes.”
Michael Gollob, MD, FRCPC
Scientist, Toronto General Hospital Research Institute (TGHRI)
Toronto, Canada

“I am writing to recommend the services of Geneyx analysis platform”

“I am writing to recommend the services of Geneyx analysis platform. I have been using the Geneyx Analysis platform for the last 4 years to analyze genetic data from ~700 children with rare disorders including from the Department of Pediatrics and Adolescent Medicine using Whole Exome Sequencing and, most recently, Whole Genome Sequencing. They have been reasonably priced and willing to provide great customer service in a timely manner. I am happy to recommend the service of the Geneyx Analysis platform.”
Dr. Brian Chung
Clinical Associate Professor, Department of Pediatrics and Adolescent Medicine
Li Ka shing Faculty of Medicine The University of Hong Kong

“A very cost-effective tool in our hands”

“We have been using the Geneyx software for the last 2 years. We have analyzed for clinical purposes a total of approximately 1000 NGS sequences of exomes (WES) and genomes (WGS). We are very satisfied with the Geneyx software as it is easy to use and provides a ranking of variants as a cause of the patients’ phenotype that we have found to be very informative. This ranking allows an easy screening for causing variants which saves analysis time and increases the diagnostic yield. This last point, together with the actual cost per sample results in a very cost-effective tool in our hands.”
Damià Heine Suñer, PhD
Molecular Geneticist Molecular Diagnostics and Clinical Genetics Unit Hospital Universitari Son Espases
Mallorca, Spain
Previous
Next

“Geneyx Analysis is at the highest level, and with extraordinary bioinformatics pipelines”

“The Geneyx platform for genetic analysis is at the highest level, and with extraordinary bioinformatic pipelines. Geneyx will assist us in making impactful discoveries for gene-elusive sudden death arrhythmia syndromes.”
Michael Gollob, MD, FRCPC
Scientist, Toronto General Hospital Research Institute (TGHRI)
Toronto, Canada

“I am writing to recommend the services of Geneyx analysis platform”

“I am writing to recommend the services of Geneyx analysis platform. I have been using the Geneyx Analysis platform for the last 4 years to analyze genetic data from ~700 children with rare disorders including from the Department of Pediatrics and Adolescent Medicine using Whole Exome Sequencing and, most recently, Whole Genome Sequencing. They have been reasonably priced and willing to provide great customer service in a timely manner. I am happy to recommend the service of the Geneyx Analysis platform.”
Dr. Brian Chung
Clinical Associate Professor, Department of Pediatrics and Adolescent Medicine
Li Ka shing Faculty of Medicine The University of Hong Kong

“A very cost-effective tool in our hands”

“We have been using the Geneyx software for the last 2 years. We have analyzed for clinical purposes a total of approximately 1000 NGS sequences of exomes (WES) and genomes (WGS). We are very satisfied with the Geneyx software as it is easy to use and provides a ranking of variants as a cause of the patients’ phenotype that we have found to be very informative. This ranking allows an easy screening for causing variants which saves analysis time and increases the diagnostic yield. This last point, together with the actual cost per sample results in a very cost-effective tool in our hands.”
Damià Heine Suñer, PhD
Molecular Geneticist Molecular Diagnostics and Clinical Genetics Unit Hospital Universitari Son Espases
Mallorca, Spain

Schedule Demo

Contact us to set a live demo